Health Care AMGN Infographic: Amgen’s Q4 2022 profit drops on flat revenues 3 years ago Amgen Inc. (NASDAQ: AMGN) said its revenues remained unchanged in the fourth quarter of 2022 when the biotechnology firm's earnings… HUM Earnings: Highlights of Humana’s Q4 2022 financial results 3 years ago Humana Inc. (NYSE: HUM) on Wednesday reported fourth-quarter 2022 results. Adjusted profit increased from last year, aided by a 7%… BSX Infographic: Highlights of Boston Scientific’s Q4 2022 earnings report 3 years ago Medical device maker Boston Scientific Corporation (NYSE: BSX) has announced financial results for the fourth quarter of 2022, reporting a… GlaxoSmithKline plc (GSK) Q4 2022 Earnings Call Transcript 3 years ago GlaxoSmithKline plc (NYSE: GSK) Q4 2022 earnings call dated Feb. 01, 2023 Corporate Participants: Nick Stone -- Head of Global Investor Relations… Pfizer (PFE) expects COVID franchise to reach low point in 2023 and then rebound in 2024 3 years ago Shares of Pfizer Inc. (NYSE: PFE) were up on Tuesday despite the company delivering mixed results for the fourth quarter… PFE Earnings: Key quarterly highlights from Pfizer’s Q4 2022 financial results 3 years ago Pfizer Inc. (NYSE: PFE) reported fourth quarter 2022 earnings results today. Revenues increased 2% year-over-year to $24.3 billion but missed estimates.… Should you buy CVS Health (CVS) stock before Q4 earnings? 3 years ago CVS Health Corporation (NYSE: CVS), the largest retail pharmacy chain, is on a mission to make quality healthcare available to… Abbott Laboratories (ABT) Q4 2022 Earnings Call Transcript 3 years ago Abbott Laboratories (NYSE:ABT) Q4 2022 Earnings Call dated Jan. 25, 2023. Corporate Participants: Scott Leinenweber -- Vice President of Investor Relations, Licensing,… Intuitive Surgical (ISRG) Earnings: 4Q22 Key Numbers 3 years ago Intuitive Surgical, Inc. (NASDAQ: ISRG) reported revenue of $1.66 billion for the fourth quarter of 2022, which was up 7%… Infographic: How Abbott Laboratories (ABT) performed in Q4 2022 financial results 3 years ago Abbott Laboratories (NYSE: ABT) reported fourth quarter 2022 earnings results today. Net sales declined 12% year-over-year to $10.1 billion. Net… Next» « Previous